scispace - formally typeset
C

Christof Hiebel

Researcher at University of Mainz

Publications -  11
Citations -  446

Christof Hiebel is an academic researcher from University of Mainz. The author has contributed to research in topics: Proteostasis & BAG3. The author has an hindex of 9, co-authored 11 publications receiving 370 citations.

Papers
More filters
Journal ArticleDOI

Protein homeostasis, aging and Alzheimer's disease.

TL;DR: Since aging is accompanied by changes in cellular protein homeostasis and an increasing demand for protein degradation, aspects of protein folding, misfolding, refolding and, importantly, protein degradation need to be linked to AD pathogenesis.
Journal ArticleDOI

RAB3GAP1 and RAB3GAP2 modulate basal and rapamycin-induced autophagy.

TL;DR: RAB3GAP1/2 is identified as novel conserved factors of the autophagy and proteostasis network and is analyzed in relation to the previously reported suppressive Autophagy modulators FEZ1 and FEZ2 and demonstrate that both reciprocally regulate autophileagy.
Journal ArticleDOI

Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function.

TL;DR: A novel non-canonical autophagy pathway is uncovers that might be an interesting target for personalized medicine and treatment of ERα-positive breast cancer cells that do not respond to anti-hormone therapy and classical Autophagy inhibitors.
Journal ArticleDOI

Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis.

TL;DR: The most effective inhibitor, MK-2206 exerted a rescue effect by restoring autophagy in ΔF508 CFBE41o- cells, and the potential of the PI3K/Akt/mTOR pathway for therapeutic targeting in CF is demonstrated.
Journal ArticleDOI

Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition

TL;DR: It is indicated that CB1 deficiency can worsen AD-related cognitive deficits and support a potential role of CB1 as a pharmacologic target.